Health Trials

Localized Cutaneous Leishmaniasis

1

Review clinical trials related to Localized Cutaneous Leishmaniasis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).

The purpose of this clinical trial is to measure efficacy, safety and pharmacokinetics (PK) of two LXE408 oral regimens and oral miltefosine tablets as active control in localized cutaneous leishmaniasis in the region of the Americas (AMR), and assess its suitability for use in monotherapy for the treatment of patients with cutaneous leishmaniasis (CL).

Participants needed: 250
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Drugs for Neglected DiseasesUpdated: May 5, 2026Locations: 5
Eligibility criteria

Participant must be aged ≥18 years old and weighing > 50kg [+8]

Female with a positive blood pregnancy test at screening or who is breastfeeding... [+14]

Read more